U.S. drug sales gain 5.
Drugs of the United States increased by 5.4% in 2005 - driven by increased use of biotechnology products and the reduction of drugs purchased abroad - and should continue to increase every year at least at this rate until in 2010, according to a report released Wednesday by IMS Health, reports Bloomberg Inquirer / Philadelphia. Sales in 2005 reached 251.8 billion dollars against 238.9 billion dollars in 2004. Biotech drugs such as Genentechs Rituxan in the treatment of cancer and anemia treatment Aranesp Amgen has had a 17.2% of increased sales, reaching $ 32.8 billions. Sales of drugs obtained from Canada through Internet pharmacies decreased by 23% to U.S. $ 349 million, helping to keep U.S. sales, Bloomberg / Inquirer reports. According to Bloomberg / Inquirer, sales increased
in 2005, despite the FDA approval of a smaller number of new products, some drug triggers the production lower than expected sales and increased competition from generics. By 2006, seven new drugs, such as anti-cancer drug Sutent Pfizers inhaled insulin and inhaled, it expects sales of at least $ 1 billion, according to Bloomberg / Inquirer.Prescription sales expected to increase by 5% to 8% per year for five years with the start of the new Medicare benefit, which could stimulate an increase of 1% to 2% in 2006 sales, according to IMS. So far in 2006, the number of prescriptions for consumers aged over 64 increased by about 5% over the same period in 2005.Comments of prescription volumes are increasing, demonstrating the growing demand for pharmaceutical products at prices
below the market has undergone in the past. We expect this trend to continue throughout this year, millions of seniors will begin receiving coverage for Medicare prescription drugs, the spokesman for IMS Diana Conmy said. IMS spokesman Marc Benoff added, the import is not an important issue as the market as it was two years ago. Miller Tabak analyst said Funtleyder Co. in 2004 and 2005 was the lowest point of new products.The increasing preventive care in the united states would reducePages: [1] 2